More News

08 May 2019 Pfizer Acquires Clinical-Stage Biotech Therachon
03 May 2019 Amgen And Syapse Enter Precision Medicine Collaboration In Oncology
02 May 2019 Transgene and AstraZeneca enter into a collaboration and exclusive license option agreement for innovative Invir.IOTM based armed oncolytic immunotherapies
01 May 2019 Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers
01 May 2019 AstraZeneca starts artificial intelligence collaboration to accelerate drug discovery
30 Apr 2019 Sandoz enters agreement for proposed trastuzumab biosimilar, currently in Phase III development, to treat selected HER2-positive cancer tumors
29 Apr 2019 Iktos Announces Research Collaboration with Janssen to Utilize Iktos’ Artificial Intelligence Technology to Increase Speed & Efficiency of Small Molecule Drug Discovery
29 Apr 2019 Calixar signs exclusive licensing agreement with Regeneron on undisclosed therapeutic target
25 Apr 2019 Daiichi Sankyo Selects Lead Candidate Built on Zymeworks’ Azymetric™ Bispecific Platform
25 Apr 2019 Salix Enters Into Exclusive License Agreement With Mitsubishi Tanabe Pharma To Develop And Commercialize Late Stage Investigational S1P Modulator For The Treatment Of Inflammatory Bowel Disease
23 Apr 2019 Lilly and Avidity Biosciences Announce Licensing and Research Collaboration
23 Apr 2019 Variant Pharmaceuticals Expands Development Focus Into $60+ Billion Anti-inflammatory Market with Worldwide License to Novel Inflammasome Inhibitor
23 Apr 2019 Fulcrum Therapeutics Acquires Global Rights to Losmapimod, a Potential Disease-Modifying Therapy for Facioscapulohumeral Muscular Dystrophy
18 Apr 2019 Arrakis Therapeutics Announces $75 Million Series B Financing to Advance a New Class of Small-Molecule Medicines Targeting RNA
17 Apr 2019 CASI Pharmaceuticals In-Licenses Exclusive Worldwide Rights to Novel Anti-CD38 Monoclonal Antibody Program From Black Belt Therapeutics
17 Apr 2019 RNA Therapeutics Startup Panorama Medicine Raises $3.7 Million to Accelerate Drug Discovery Using Genomics and Artificial Intelligence
17 Apr 2019 PureTech Health Announces Collaboration with Boehringer Ingelheim to Advance Immuno-oncology Product Candidates using its Lymphatic Targeting Platform
17 Apr 2019 Gilead and insitro Announce Strategic Collaboration to Discover and Develop Novel Therapies for Nonalcoholic Steatohepatitis
15 Apr 2019 Allele Biotechnology and SCM Lifescience Sign a Joint Research and Development Agreement to Develop iPSC-based Diabetes Treatment
12 Apr 2019 Gyroscope Therapeutics merges with Orbit Biomedical creating a leading retinal gene therapy company
12 Apr 2019 Ophthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal Diseases
12 Apr 2019 Gilead Sciences and Novo Nordisk Announce Intent to Initiate a Clinical Collaboration in NASH
10 Apr 2019 Synaffix Announces License Agreement Worth up to $125 Million with Leading Chinese ADC Developer, Shanghai Miracogen
09 Apr 2019 BioAtla and BeiGene Form Worldwide Collaboration to Develop and Commercialize Novel Conditionally Active Biologic CTLA-4 Therapy
09 Apr 2019 Enesi Pharma and University of Oxford Collaborate to Target Plague With a Novel ImplaVax®-enabled Adenovirus-based Solid Dose Vaccine

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top